Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women

Blanca Murillo-Ortiz,1 Sandra Martínez-Garza,1 David Suárez García,1 Rosa del Carmen Castillo Valenzuela,2 Juan Francisco García Regalado,2 Gerardo Cano Velázquez1 1Institute Mexican of Social Security, Department Oncology, Unit of Research in C...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Murillo-Ortiz B, Martínez-Garza S, Suárez García D, Castillo Valenzuela RDC, García Regalado JF, Cano Velázquez G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Telomere length CYP19 polymorphism breast cancer Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/fbce81fdc8424637b1e9889712a29be4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fbce81fdc8424637b1e9889712a29be4
record_format	dspace
spelling	oai:doaj.org-article:fbce81fdc8424637b1e9889712a29be42021-12-02T07:04:42ZAssociation between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women1179-1314https://doaj.org/article/fbce81fdc8424637b1e9889712a29be42017-01-01T00:00:00Zhttps://www.dovepress.com/association-between-telomere-length-and-cyp19-ttta-repetition-polymorp-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Blanca Murillo-Ortiz,1 Sandra Martínez-Garza,1 David Suárez García,1 Rosa del Carmen Castillo Valenzuela,2 Juan Francisco García Regalado,2 Gerardo Cano Velázquez1 1Institute Mexican of Social Security, Department Oncology, Unit of Research in Clinical Epidemiology, 2Department of Medical Sciences, University of Guanajuato, León Guanajuato, Mexico Introduction: Several studies have reported an increase in breast cancer (BC) risk when patients are carriers of the CYP19 TTA polymorphism with ≥10 repeats; moreover, it has been reported that telomere length is associated with a higher susceptibility of developing cancer. Objective: The objective of this study was to understand the relationship between CYP19 TTTA repetition polymorphism and telomere length and its effects on serum estradiol, estrone and follicle-stimulating hormone (FSH). Materials and methods: A total of 180 postmenopausal healthy and 70 BC-diagnosed women were included. Telomere length was determined through real-time quantitative polymerase chain reaction, and aromatase polymorphism was analyzed through DNA; both samples were obtained from circulating leukocytes. Serum estrone, estradiol and FSH were determined by enzyme-linked immunosorbent assay. Results: Patients with a BC diagnosis showed >10 repetitions more frequently, compared with that of healthy women (50% vs 23%, Χ2 =11.44, p=0.0007). A significant difference in telomere length between healthy and BC women was observed (5,042.7 vs 2,256.7 pb, Z=4.88, p<0.001). CYP19 TTTA repeat polymorphism was associated with serum levels of estradiol and estrone in both groups, being higher in those with >10 repeats. Moreover, telomere length showed an inverse relationship with the number of repeats of the aromatase polymorphism in healthy women (R2=0.04, r= -0.24); in contrast, BC patients did not display this relationship. In addition, telomere length presented an inverse relationship with serum levels of estradiol and estrone in BC patients (p=0.02). Conclusion: Telomere length is shorter in BC patients than in healthy patients. The CYP19 TTTA repeat polymorphism is associated with serum levels of estradiol and estrone in both healthy women and BC patients, being higher in those with polymorphism carriers >10 repeats. Telomere length has an inverse correlation with the number of repeats of the aromatase polymorphism in healthy women but not in BC women. Estradiol and estrone levels in BC women have an inverse relationship with telomere length. Keywords: telomere length, CYP19 polymorphism, breast cancerMurillo-Ortiz BMartínez-Garza SSuárez García DCastillo Valenzuela RDCGarcía Regalado JFCano Velázquez GDove Medical PressarticleTelomere lengthCYP19 polymorphismbreast cancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol Volume 9, Pp 21-27 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Telomere length CYP19 polymorphism breast cancer Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Telomere length CYP19 polymorphism breast cancer Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Murillo-Ortiz B Martínez-Garza S Suárez García D Castillo Valenzuela RDC García Regalado JF Cano Velázquez G Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women
description	Blanca Murillo-Ortiz,1 Sandra Martínez-Garza,1 David Suárez García,1 Rosa del Carmen Castillo Valenzuela,2 Juan Francisco García Regalado,2 Gerardo Cano Velázquez1 1Institute Mexican of Social Security, Department Oncology, Unit of Research in Clinical Epidemiology, 2Department of Medical Sciences, University of Guanajuato, León Guanajuato, Mexico Introduction: Several studies have reported an increase in breast cancer (BC) risk when patients are carriers of the CYP19 TTA polymorphism with ≥10 repeats; moreover, it has been reported that telomere length is associated with a higher susceptibility of developing cancer. Objective: The objective of this study was to understand the relationship between CYP19 TTTA repetition polymorphism and telomere length and its effects on serum estradiol, estrone and follicle-stimulating hormone (FSH). Materials and methods: A total of 180 postmenopausal healthy and 70 BC-diagnosed women were included. Telomere length was determined through real-time quantitative polymerase chain reaction, and aromatase polymorphism was analyzed through DNA; both samples were obtained from circulating leukocytes. Serum estrone, estradiol and FSH were determined by enzyme-linked immunosorbent assay. Results: Patients with a BC diagnosis showed >10 repetitions more frequently, compared with that of healthy women (50% vs 23%, Χ2 =11.44, p=0.0007). A significant difference in telomere length between healthy and BC women was observed (5,042.7 vs 2,256.7 pb, Z=4.88, p<0.001). CYP19 TTTA repeat polymorphism was associated with serum levels of estradiol and estrone in both groups, being higher in those with >10 repeats. Moreover, telomere length showed an inverse relationship with the number of repeats of the aromatase polymorphism in healthy women (R2=0.04, r= -0.24); in contrast, BC patients did not display this relationship. In addition, telomere length presented an inverse relationship with serum levels of estradiol and estrone in BC patients (p=0.02). Conclusion: Telomere length is shorter in BC patients than in healthy patients. The CYP19 TTTA repeat polymorphism is associated with serum levels of estradiol and estrone in both healthy women and BC patients, being higher in those with polymorphism carriers >10 repeats. Telomere length has an inverse correlation with the number of repeats of the aromatase polymorphism in healthy women but not in BC women. Estradiol and estrone levels in BC women have an inverse relationship with telomere length. Keywords: telomere length, CYP19 polymorphism, breast cancer
format	article
author	Murillo-Ortiz B Martínez-Garza S Suárez García D Castillo Valenzuela RDC García Regalado JF Cano Velázquez G
author_facet	Murillo-Ortiz B Martínez-Garza S Suárez García D Castillo Valenzuela RDC García Regalado JF Cano Velázquez G
author_sort	Murillo-Ortiz B
title	Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women
title_short	Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women
title_full	Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women
title_fullStr	Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women
title_full_unstemmed	Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women
title_sort	association between telomere length and cyp19 ttta repetition polymorphism in healthy and breast cancer-diagnosed women
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/fbce81fdc8424637b1e9889712a29be4
work_keys_str_mv	AT murilloortizb associationbetweentelomerelengthandcyp19tttarepetitionpolymorphisminhealthyandbreastcancerdiagnosedwomen AT martinezgarzas associationbetweentelomerelengthandcyp19tttarepetitionpolymorphisminhealthyandbreastcancerdiagnosedwomen AT suarezgarciad associationbetweentelomerelengthandcyp19tttarepetitionpolymorphisminhealthyandbreastcancerdiagnosedwomen AT castillovalenzuelardc associationbetweentelomerelengthandcyp19tttarepetitionpolymorphisminhealthyandbreastcancerdiagnosedwomen AT garciaregaladojf associationbetweentelomerelengthandcyp19tttarepetitionpolymorphisminhealthyandbreastcancerdiagnosedwomen AT canovelazquezg associationbetweentelomerelengthandcyp19tttarepetitionpolymorphisminhealthyandbreastcancerdiagnosedwomen
_version_	1718399672002805760

Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women

Ejemplares similares